Eli Lilly and Company has agreed to acquire SiteOne Therapeutics Inc., a private biotech company developing small molecule ...

GRIN Therapeutics Inc. and Angelini Pharma have partnered for the development and commercial rights outside of North America ...

Sapio Sciences, the science-aware lab informatics platform, has promoted Gordon McCall to Chief Operating Officer (COO).

Hansa Biopharma AB, which appointed a new CEO and COO earlier this year, has announced plans to restructure its organization.

The award jury recognizes strategic and sustainable corporate management.

Lifecore Biomedical Inc., a fully integrated CDMO, has appointed Mark DaFonseca as its Chief Commercial Officer.

Today’s pharma companies must rethink contract packaging and find partners that go beyond providing packaging services and instead enhance their manufacturing processes with flexibility and a ...

This transition reflects a planned and strategic evolution of MC2 Therapeutics, aligned with the company’s focus on commercial expansion.

The U.S. Food and Drug Administration (FDA) has approved STARJEMZA Injection, a biosimilar referencing Stelara (ustekinumab) Injection.